
Gretel Terrero, MD
@gretelterrero
Gastrointestinal Medical Oncologist @SylvesterCancer via @UMiamiHealth @BIDMC_IM @BrownMedicine @BrownUniversity
ID: 1134948186118873088
https://dolphinscancerchallenge.com/participant/Gretel-Terrero 01-06-2019 22:21:48
209 Tweet
320 Followers
263 Following



🔬 #Glioblastoma is the most common brain tumor in adults, yet treatment progress has stalled for 20 years. Dr. Ashish H. Shah’s new study at Sylvester identifies ZNF638 as a key target to boost immune response and improve #immunotherapy for glioblastoma. 🙌loom.ly/AjQPQZY

Honored to present our attrition data for patients with localized PDAC undergoing NAT and reasons for failure to undergo successful pancreatectomy at #SSO2025 Society of Surgical Oncology


Recently, we launched our first PanCAN Community Conversations in Houston, Miami, and Seattle! These events featured a panel of local doctors and survivors, a #PanCANVolunteer, and PanCAN President Julie Fleshman, JD, MBA, alongside PanCAN Chief Scientific and Medical Officer


Interested in myeloid cell anti-tumor immunity? I’ll be presenting at National Cancer Institute Rising Scholars Seminar Series on 17 Apr our work on Fc-optimized CD40 Agonistic Antibody and TLS formation and induction of Systemic Antitumor Immunity cassyni.com/events/Eg84FXZ…


Thoracic Onc folks 🛑 what you’re doing You received an email today to vote for IASLC board of directors PLEASE take 2 mins to vote for Narjust Florez, MD, FASCO under undesignated seat #4. We need someone like HER to implement real changes! Now GO gilberto lopes Toni Choueiri, MD Dr. Estela Rodriguez

Just consented our first patient for the investigator-initiated SVV + Ipi-Nivo trial. A big step forward in our fight against high-grade neuroendocrine cancers. We need better treatments—wish us luck! Sylvester Comprehensive Cancer Center Miller Medicine news.med.miami.edu/clinical-trial…


Proud and honored to represent Sylvester Comprehensive Cancer Center at this year’s PanCAN #PurpleStride Miami. Feeling motivated and inspired by our survivors, patients, caretakers, and team of experts focused on advancing this field. 💜 Terri Pollack Peter Hosein, MD Jash Datta, MD Emilia Mason, Ph.D.


If you would like to learn more about our recently launched high-grade neuroendocrine cancer study, please check out the brief primer linked below. Many thanks to Neuroendocrine Cancer Foundation for the opportunity to discuss our study and for curating important clinical trial information on your



Congratulations!! Kyle Edwards and Coral Olazagasti, MD !! 🫁🚭🔊🟧🙌🏼🟩


Thank you OncLive.com Benjamin Levy for organizing fellows forum! An incredible learning opportunity. Eric K. Singhi, MD Narjust Florez, MD, FASCO Sandip Patel MD FASCO Christine Garcia, MD, MPH Kristen A. Marrone, MD Sylvester Comprehensive Cancer Center

This morning, I had the honor of presenting my first Rapid Oral at #ASCO25 🎤 — a truly unforgettable experience ✨. Our study highlights the rising burden of #alcohol-associated cancers 🍷🎗️ across sites, age groups, and sexes gilberto lopes Dr. Estela Rodriguez . Grateful to all my mentors


Future 🌟onc fellow Dan Morgenstern, MD, MSc presents our poster on the multiomic landscape of LRRC15 in TNBC highlighting the potential of emerging molecular markers to guide new treatment strategies. Work from Sylvester Comprehensive Cancer Center in collaboration with Caris Life Sciences 📍 Metastatic Breast Poster

Excited to present our #ASCO25 poster on the RADICAL trial! 🎯 📌 Radium-223 + Cabozantinib vs Cabozantinib in RCC with bone mets 🎯 SSE-free survival, PFS, OS, QOL, liquid + tissue biomarkers 🧪 Trial OPEN for accrual! Thanks to Rana McKay, MD, FASCO for your mentorship and


